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A B S T R A C T
In this study, our aim was to develop solid drug-cyclodextrin inclusion complex system having
nanofibrous morphology in order to have fast-dissolving property and enhanced water-solubility of
poorly water-soluble drug. Here, we prepared a highly concentrated aqueous solution of inclusion
complex between sulfisoxazole and sulfobutyl ether7-beta-cyclodextrin (SBE7-b-CD, Captisol1), and
then, without using any polymeric matrix, the electrospinning of sulfisoxazole/SBE7-b-CD-IC nanofibers
was performed in order to obtain free-standing and handy nanofibrous web. As a control sample,
nanofibers from pure SBE7-b-CD was also electrospun and free-standing nanofibrous web was obtained.
The SEM imaging revealed that the bead-free and uniform nanofiber morphology with the average fiber
diameter (AFD) of 650  290 nm for sulfisoxazole/SBE7-b-CD-IC NF and 890  415 nm for pure SBE7-b-CD
NF was obtained. The inclusion complex formation between sulfisoxazole and SBE7-b-CD in
sulfisoxazole/SBE7-b-CD-IC NF sample was confirmed by 1H NMR, TGA, DSC, XRD and FTIR analyses.
Due to the combined advantage of cyclodextrin inclusion complexation and high surface area of
electrospun nanofibers, fast-dissolving property with enhanced water-solubility was successfully
achieved for sulfisoxazole/SBE7-b-CD-IC NF. Our findings suggest that electrospun nanofibers/nanowebs
from CD-IC of poorly water-soluble drugs may offer applicable approaches for high water-solubility and
fast-dissolving tablet formulations for drug delivery systems.
© 2017 Elsevier B.V. All rights reserved.
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Cyclodextrins (CDs) are cyclic oligosaccharides having either 6,
7, or 8 glucopyranose units linked by a-1,4 linkages in the cycle and
are named as a-CD, b-CD and g-CD, respectively (Szejtli, 1998).
CDs have truncated cone-shaped molecular structure which can
form supramolecular structures by forming non-covalent host-
guest inclusion complexes with variety of molecules (Szejtli,1998).
The inner side of the CD is relatively hydrophobic and the outer
side is hydrophilic which makes CDs to form inclusion complexes
with various hydrophobic molecules including drug molecules
(Ogawa et al., 2015). One of the main problems in pharmaceutical
industry is low water-solubility of the drugs which result in
decrease in bioavailability; nevertheless, the inclusion complex
formation of drugs with cyclodextrins overcomes this problem and* Corresponding author.
E-mail addresses: tamer@unam.bilkent.edu.tr, tameruyar@gmail.com (T. Uyar).
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0378-5173/© 2017 Elsevier B.V. All rights reserved.enhances the bioavailability of the drugs by increasing their water-
solubility. But, native cyclodextrins (a-CD, b-CD and g-CD) have
lower water-solubility which sometimes restricted their use in
pharmaceutical formulation. Yet, chemically modified CD deriv-
atives such as hydroxypropyl-CD, methylated-CD, sulfobutyl ether-
CD have much higher water solubility. Sulfobutyl ether-beta-
cyclodextrin (SBE7-b-CD, Captisol1) is sulfobutyl derivative of
b-CD with a 6.6 average degree of substitution (Fig. 1a). This
substitution decreases nephrotoxicity of cyclodextrin while
increases its aqueous solubility to a great extent (Beig et al.,
2015). One of the distinctive features of SBE7-b-CD is extension of
the cavity due to repulsion of end groups' negative charges which
provides stronger binding to the drug molecules (Beig et al., 2015).
The other feature is the presence of negative charges in SBE7-b-CD
at physiological pH which makes binding with a positively charged
drug molecule possible. Therefore, the inclusion complex forma-
tion with SBE7-b-CD has advantages for drug delivery systems.
The application of inclusion complexes of CDs with drug may be
widen by the incorporation of such molecular complexation
Fig. 1. (a) The chemical structure of sulfisoxazole and SBE7-b-CD with a schematic representation of sulfisoxazole, SBE7-b-CD and their IC, (b) Schematic representation of
the electrospinning of sulfisoxazole/SBE7-b-CD-IC NF.
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spinning, being one of the versatile methods for nanofiber
production, enables us to produce nanofibers and nanofibrous
webs having high surface area to volume ratio, nano-scale porosity
and design flexibility for chemical/physical functionalization, etc.
Due to their exceptional properties, it has been shown that
electrospun nanofibers and their nanomats/nanowebs have
potential use in various application areas in biotechnology,
membranes/filters, food, agriculture, sensor, energy etc, (Aytac
et al., 2015, 2017; Noruzi, 2016; Sahay et al., 2012; Uyar and Kny,
2017). Electrospun nanofibers could also be used for drug delivery
systems for targeted delivery and/or for inhibition of drug adverse
side effects with controlled release (Aytac et al., 2015; Mendes
et al., 2016; Wang et al., 2016).
Electrospun polymeric nanofibers incorporating drug-cyclo-
dextrin inclusion complexes (CD-ICs) have shown to be promising
matrix for drug release systems (Aytac et al., 2015; Aytac and Uyar,
2017; Tonglairoum et al., 2013). For instance, Siafaka et al. (2016)
has performed a study on the comparison of electrospun nano-
fibers and cyclodextrin as drug delivery system suggesting that
both systems were good for drug delivery and showed similar
efficiency. In our approach, we combine the efficiency of
cyclodextrin inclusion complexation and high surface area of
electrospun nanofibers for effective drug delivery system. Sinceelectrospinning of nanofibers from small molecules is quite a
challenge, mostly polymeric matrix is needed to obtain nanofibers
(Uyar and Kny, 2017; Wendorff et al., 2012). Nevertheless, in our
recent studies we achieved the electrospinning of nanofibers from
pure cyclodextrin types (native CDs and modified CDs) (Celebioglu
and Uyar, 2012, 2013; Celebioglu et al., 2014b) and CD-ICs
(Celebioglu and Uyar, 2011; Celebioglu et al., 2014a, 2016; Aytac
et al., 2016a,b) without using polymeric carrier matrix.
Sulfonamides are synthetic drugs known by their antimicrobial
effects on different pathogenic microorganisms (Ta9cic et al., 2014).
However, the use of these types of drugs is sometimes limited due
to their poor water-solubility. The oxazole subtituted sulfonamide
is called as sulfisoxazole (Fig. 1a). Sulfisoxazole is a weak acid and
slightly soluble in water. In this study, our aim was to develop
nanofibrous sulfisoxazole-cyclodextrin inclusion complex system
(Fig. 1a) in order to have fast-dissolving character and enhance the
water-solubility of sulfisoxazole. Here, we prepared a highly
concentrated aqueous solution of inclusion complex between
sulfisoxazole and SBE7-b-CD, and then, without using any
polymeric matrix, sulfisoxazole/SBE7-b-CD-IC was electrospun
into nanofibrous structure to obtain a free-standing and handy
solid form (Fig. 1b). We observed that sulfisoxazole/SBE7-b-CD-IC
nanofibrous web was readily soluble in water and the water-
solubility of sulfisoxazole was enhanced significantly. Our findings
Fig. 2. Phase solubility diagram of sulfisoxazole/SBE7-b-CD systems in water
(n = 3).
552 Z.I. Yildiz et al. / International Journal of Pharmaceutics 531 (2017) 550–558suggested that sulfisoxazole/SBE7-b-CD-IC in the form of nano-
fibrous webs can be quite useful in fast-dissolving tablet
formulations for drug delivery.
2. Materials and methods
Sulfisoxazole (99%) was obtained from Sigma-Aldrich commer-
cially. SBE7-b-CD (Captisol1, average degree of substitution = 6.6)
was kindly donated by Cydex Pharmaceuticals Inc. (Kansas, USA).
Potassium bromide (KBr, 99%, FTIR grade, Sigma-Aldrich), deuter-
ated dimethylsulfoxide (d6-DMSO, deuteration degree min. 99.8%
for NMR spectroscopy, Merck) were used in this study. The waterFig. 3. Photographs of electrospun (a) SBE7-b-CD NF, (b) sulfisoxazole/SBE7-b-CD-Iused was from a Millipore Milli-Q ultrapure water system. The
materials were used as-received without any further purification
process.
2.1. Preparation of solutions
The inclusion complex solution of sulfisoxazole with SBE7-b-CD
was initially prepared by 1:1 molar ratio of sulfisoxazole:SBE7-
b-CD. However, the molar ratio was changed to 1:2 (sulfisoxazole:
SBE7-b-CD) since electrospinning of uniform nanofiber cannot be
obtained from 1:1 complex solution. Firstly, sulfisoxazole powder
was dispersed in water then SBE7-b-CD (200% (w/v)) was added to
the dispersion. After that, the solution was stirred 24 h until clear
and homogenous solution was obtained. Besides, to make
comparison, highly concentrated SBE7-b-CD (200% (w/v)) solution
without sulfisoxazole was also prepared in water for the electro-
spinning of pure SBE7-b-CD nanofibers. Sulfisoxazole/SBE7-b-CD-
IC was also obtained in the powder form in order to compare with
sulfisoxazole/SBE7-b-CD-IC NF in terms of the dissolving rate and
water solubility. Sulfisoxazole powder was dispersed in water and
then SBE7-b-CD was added with the molar ratio of 1:2
(sulfisoxazole:SBE7-b-CD). After 24 h stirring, this inclusion
complex solution was frozen at 80 C for two days and then
lyophilized in a freeze-dryer for 24 h to obtain sulfisoxazole/SBE7-
b-CD-IC powder.
2.2. Electrospinning of nanofibers
Sulfisoxazole/SBE7-b-CD-IC solution was loaded to the 1 mL
syringe fitted with a 0.4 mm inner diameter having needle. The
syringe was placed horizontally on the syringe pump (KD
Scientific, KDS 101) and the solution was pumped with rate ofC NF, and SEM images of (c) SBE7-b-CD NF, (d) sulfisoxazole/SBE7-b-CD-IC NF.
Fig. 4. 1H NMR spectra of (a) sulfisoxazole powder, (b) SBE7-b-CD NF and SBE7-b-CD powder, (c) sulfisoxazole/SBE7-b-CD-IC NF, (d) sulfisoxazole/SBE7-b-CD-IC powder.
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was placed at 10–15 cm from the tip of the needle and the applied
voltage was 10–15 kV. The electrospinning of pristine SBE7-b-CD
NF was performed with the same conditions/parameters. The
electrospinning system was enclosed by Plexiglass box and
electrospinning was performed at 25 C and 30% relative humidity.Fig. 5. (a) TGA thermograms and (b) their derivatives of sulfiso2.3. Measurements and characterizations
Phase solubility measurement was carried out according to
Higuchi and Connors (1965). An excess amount of sulfisoxazole
was added to 5 mL of aqueous solutions containing increasing
concentration of SBE7-b-CD ranging from 0 to 7.4 mM. Thexazole, SBE7-b-CD NF and sulfisoxazole/SBE7-b-CD-IC NF.
Fig. 7. XRD patterns of sulfisoxazole, SBE7-b-CD NF sulfisoxazole/SBE7-b-CD-IC NF
and sulfisoxazole/SBE7-b-CD-IC powder.
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equilibrium. Then, all suspensions were filtered by a 0.45 mm
membrane filter to remove undissolved parts and all suspensions
were diluted with water. Sulfisoxazole concentration with respect
to increasing SBE7-b-CD concentration was determined by UV–vis
spectroscopy (Varian, Cary 100) at 260 nm. The result of phase
solubility was given as a plot of the molar concentration of
sulfisoxazole versus molar concentration of SBE7-b-CD. The
apparent stability constant (Ks) of sulfisoxazole/SBE7-b-CD-IC
were calculated from the phase solubility diagram according to the
following equation:
Ks = slope/S0 (1-slope) (1)
where S0 is the intrinsic solubility of sulfisoxazole.
The samples of electrospun nanofibers (SBE7-b-CD NF and
sulfisoxazole/SBE7-b-CD-IC NF) were investigated morphological-
ly by scanning electron microscopy (SEM, FEI-Quanta 200 FEG).
Nanofibers were sputtered with 5 nm Au/Pd layer to minimize
charging by PECS-682. Average fiber diameter (AFD) for both
nanofibrous web was calculated from SEM images of 100 fibers.
The proton nuclear magnetic resonance (1H NMR, Bruker D PX-
400) system was used to determine molar ratio between
sulfisoxazole and SBE7-b-CD. In addition, SBE7-b-CD powder
was also analyzed by 1H NMR to see if there is any change due to
degradation in chemical structure of SBE7-b-CD after electro-
spinning process. 30 g L1 concentration of pure sulfisoxazole,
SBE7-b-CD powder, SBE7-b-CD NF, sulfisoxazole/SBE7-b-CD-IC NF
and sulfisoxazole/SBE7-b-CD-IC powder was dissolved in d6-
DMSO separately for the preparation of solution for 1H NMR
measurements.
Thermogravimetric analysis (TGA, TA Q500, USA) was carried
out to determine the thermal properties of sulfisoxazole, SBE7-
b-CD NF and sulfisoxazole/SBE7-b-CD-IC NF. These studies of the
samples were performed from 25 to 600 C with a heating rate of
20 C/min under nitrogen gas flow.
Differential scanning calorimetry (DSC, TA Q2000, USA) was
used to analyze inclusion complex formation between sulfisox-
azole and SBE7-b-CD. DSC measurement was performed for
sulfisoxazole, SBE7-b-CD NF, sulfisoxazole/SBE7-b-CD-IC NF and
sulfisoxazole/SBE7-b-CD-IC powder under N2. Samples were
equilibrated at 50 C and heated to 220 C with a rate of 10 C/min.Fig. 6. DSC thermogram of sulfisoxazole, SBE7-b-CD NF, sulfisoxazole/SBE7-b-CD-
IC NF and sulfisoxazole/SBE7-b-CD-IC powder.X-ray diffraction (XRD) (PANalytical X’Pert powder diffractom-
eter) measurements of pure sulfisoxazole, SBE7-b-CD NF, sulfisox-
azole/SBE7-b-CD-IC NF and sulfisoxazole/SBE7-b-CD-IC powder
were recorded by applying Cu Ka radiation in a range of 2u = 5–30
to determine the crystalline structure of the samples.
Fourier transform infrared spectrometry (FTIR, Bruker-VER-
TEX70) was used to obtain the infrared spectra of the samples. The
samples were mixed with potassium bromide (KBr) and pressed as
pellets. 64 scans were recorded between 4000 and 400 cm1 at a
resolution of 4 cm1.
The water solubility of sulfisoxazole is quite limited (Gladys
et al., 2003). Here, excess amount of sulfisoxazole (1.3 mg mL1),
and sulfisoxazole/SBE7-b-CD-IC NF and sulfisoxazole/SBE7-b-CD-
IC powder having the same amount of sulfisoxazole were added to
the water and stirred overnight. To make comparison, the solution
of sulfisoxazole with concentration of its water solubility (about
0.2 mg mL1) was also prepared and stirred overnight. After that,
all samples were filtered through a 0.45 mm membrane filter toFig. 8. FTIR spectra of sulfisoxazole, SBE7-b-CD NF and sulfisoxazole/SBE7-b-CD-IC
NF.
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wavelength plots of four samples was obtained from UV–vis
spectroscopy (Varian, Cary 100). In addition, to show the fast-
dissolving character and water-solubility enhancement of the drug
visually, the water is directly added to solid sulfisoxazole, and
sulfisoxazole/SBE7-b-CD-IC NF and sulfisoxazole/SBE7-b-CD-IC
powder samples. The videos and pictures have been taken in
which, sulfisoxazole powder and the sulfisoxazole/SBE7-b-CD-IC
NF were placed into petri dishes separately and then, 5 mL of water
was added to petri dishes. Then, to make comparison sulfisoxazole/
SBE7-b-CD-IC powder were also placed into a petri dish and then,
5 mL of water was added.
3. Results and discussion
3.1. Phase solubility studies
Phase solubility diagram plotted by sulfisoxazole concentration
versus SBE7-b-CD concentration was given in Fig. 2 which
corresponds that with increase in SBE7-b-CD concentration,
sulfisoxazole concentration also increases. The complex showed
linear trend (AL-type) demonstrating 1:1 complex formation
tendency of sulfisoxazole and SBE7-b-CD molecules. The stability
constant (Ks) was calculated as 880 M1 from the diagram
according to Eqn. (1) and this value indicates better stability
when compared to the previously done study on HPbCD by Gladys
et al. (2003).
3.2. Electrospinning of SBE7-b-CD NF and Sulfisoxazole/SBE7-b-CD-IC
NF
Since the phase solubility studies indicated 1:1 (sulfisoxazole:
SBE7-b-CD) complex formation tendency between sulfisoxazole
and SBE7-b-CD, first, we prepared 1:1 molar ratio inclusion
complex between sulfisoxazole and SBE7-b-CD by using highly
concentrated SBE7-b-CD (200% (w/v)) aqueous solution for the
complexation. However, the electrospinning of uniform nanofibersFig. 9. Water solubility diagram of *sulfisoxazole with concentration of its water
solubility (green), **excess amount of sulfisoxazole (pink), sulfisoxazole/SBE7-
b-CD-IC NF having the same excess amount of sulfisoxazole (blue), sulfisoxazole/
SBE7-b-CD-IC powder having the same excess amount of sulfisoxazole (purple).
(For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)from 1:1 molar ratio of sulfisoxazole/SBE7-b-CD-IC system was not
successful under the applied electrospinning conditions/param-
eters. Hence, we optimized the CD-IC solutions and found out that
sulfisoxazole/SBE7-b-CD-IC solution having 1:2 (sulfisoxazole:
SBE7-b-CD) molar ratio was more favorable for the electrospinning
of uniform nanofibers. As a control sample, pristine SBE7-b-CD NF
was also electrospun and we obtained bead-free and uniform
nanofiber morphology for the free-standing nanofibrous web of
SBE7-b-CD. The optimized parameters for the electrospinning of
the bead-free nanofibers from pristine SBE7-b-CD and sulfisox-
azole/SBE7-b-CD-IC systems were given in detail in experimental
section. The photos of free-standing and flexible electrospun
nanofibrous samples were given in Fig. 3a–b for pristine SBE7-
b-CD NF and sulfisoxazole/SBE7-b-CD-IC NF. The representative
SEM images of these SBE7-b-CD NF and sulfisoxazole/SBE7-b-CD-
IC NF samples were given in Fig. 3c–d, respectively. From the SEM
images, the average fiber diameter (AFD) for sulfisoxazole/SBE7-
b-CD-IC NF and pristine SBE7-b-CD NF was calculated as
650  290 nm and 890  415 nm, respectively.
3.3. Structural characterization of SBE7-b-CD NF and Sulfisoxazole/
SBE7-b-CD-IC NF
The structural characterization of SBE7-b-CD NF, sulfisoxazole/
SBE7-b-CD-IC NF and sulfisoxazole/SBE7-b-CD-IC powder samples
was done by using the different methods. 1H NMR spectroscopy
was used to obtain molar ratio of sulfisoxazole to SBE7-b-CD in the
sulfisoxazole/SBE7-b-CD-IC NF matrix and sulfisoxazole/SBE7-
b-CD-IC powder. The 1H NMR spectra of sulfisoxazole, SBE7-
b-CD powder, SBE7-b-CD NF, sulfisoxazole/SBE7-b-CD-IC NF and
sulfisoxazole/SBE7-b-CD-IC powder were evaluated (Fig. 4a–d).
Protons of SBE7-b-CD NF and as-received powder SBE7-b-CD were
appeared in the range of d 1.5–5.8 ppm which is correlated with
previous literature (Devasari et al., 2015; Kulkarni and Belgamwar,
2017). As shown in Fig. 4b, the 1H NMR spectra of SBE7-b-CD
powder and SBE7-b-CD NF present the same characteristic shifts
which indicated that the electrospinning process did not cause any
chemical degradation to the structure of SBE7-b-CD. The molar
ratio was calculated from integration of peak ratio between peak of
sulfisoxazole at around 7.35 (H-a) and SBE7-b-CD peak at around
5.00 ppm (H-1) as 0.28:1.00 for both sulfisoxazole/SBE7-b-CD-IC
NF and sulfisoxazole/SBE7-b-CD-IC powder (Fig. 4c–d). This
suggests that more than 50% (w/w) of initial sulfisoxazole amount
was preserved for both nanofibrous web and powder form.
The thermal decomposition of sulfisoxazole, SBE7-b-CD NF and
sulfisoxazole/SBE7-b-CD-IC NF were investigated by thermal
gravimetric analysis (TGA) (Fig. 5). The weight losses below
100 C belong to the water loss for all samples. Pure sulfisoxazole
decomposition occured between 190- 400 C while SBE7-b-CD NF
exhibited main degredation between 250 and 500 C. Along with
this, thermal decomposition of sulfisoxazole/SBE7-b-CD-IC NF
started at 220 C and continued up to 500 C. There are two
differences between SBE7-b-CD NF and sulfisoxazole/SBE7-b-CD-
IC NF degradation. First one is the small step starting at 220 C
which possibly belong to the sulfisoxazole. The shifting of thermal
decomposition onset of sulfisoxazole from 190 C to 220 C showed
the IC formation between sulfisoxazole and SBE7-b-CD. The second
difference is the intensity of peak at 300 C which also proves the
formation of inclusion complexes.
DSC is one of the widely used techniques to evaluate IC
formation between CD and guest molecule in such a way that the
melting point of guest molecules is not observed if guest molecules
fully complexed within the CD cavities (Uyar et al., 2006). The DSC
scans of pure sulfisoxazole, SBE7-b-CD NF, sulfisoxazole/SBE7-
b-CD-IC NF and sulfisoxazole/SBE7-b-CD-IC powder were given in
Fig. 6. The pure sulfisoxazole DSC scan exhibited a melting point at
Fig. 10. Presentation of the solubility behaviour of sulfisoxazole (represented by “SFO”), sulfisoxazole/SBE7-b-CD-IC NF and sulfisoxazole/SBE7-b-CD-IC powder for a few
seconds of water exposure. The pictures were captured from the videos which were given as Supporting information.
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for the samples of sulfisoxazole/SBE7-b-CD-IC NF and sulfisox-
azole/SBE7-b-CD-IC powder. The DSC results further confirm that
the sulfisoxazole molecules are fully complexed with SBE7-b-CD in
the samples of sulfisoxazole/SBE7-b-CD-IC NF and sulfisoxazole/
SBE7-b-CD-IC powder.
The crystalline structures of pure sulfisoxazole, SBE7-b-CD NF,
sulfisoxazole/SBE7-b-CD-IC NF and sulfisoxazole/SBE7-b-CD-IC
powder were investigated by XRD to show the evidence of IC
formation between sulfisoxazole and SBE7-b-CD. Sulfisoxazole is a
crystalline material having a sharp diffraction peaks at different 2u
values; however, the XRD pattern of SBE7-b-CD NF, sulfisoxazole/
SBE7-b-CD-IC NF and sulfisoxazole/SBE7-b-CD-IC powder are very
similar which have amorphous structures. The sulfisoxazole/SBE7-
b-CD-IC NF and sulfisoxazole/SBE7-b-CD-IC powder do not show
any diffraction peaks of sulfisoxazole (Fig. 7). In other words, XRD
results revealed the IC formation between sulfisoxazole and SBE7-
b-CD in the samples of sulfisoxazole/SBE7-b-CD-IC NF and
sulfisoxazole/SBE7-b-CD-IC powder. The XRD result suggests that
sulfisoxazole molecules are isolated from each other by entering
into SBE7-b-CD cavities and cannot form any crystalline aggre-
gates. Since drugs in crystalline forms are more stable, their
solubility decreases (Babu and Nangia, 2011); however, CD-ICformation prevent crystallization of drugs. Therefore, the solubility
of sulfisoxazole increases by SBE7-b-CD-IC formation since the
crystallization of sulfisoxazole was prevented as confirmed by the
XRD pattern.
The presence of guest molecule in structure and the formation
of inclusion complexes between host and guest molecule can be
proved by FTIR analysis. The FTIR spectra of pure sulfisoxazole,
SBE7-b-CD NF and sulfisoxazole/SBE7-b-CD-IC NF are represented
in Fig. 8. The FTIR spectrum of sulfisoxazole displayed salient peaks
at 876–688 cm1 range (CH bending), at 1347 cm1, (SO2
stretching); at 1326 cm1 (aromatic ring stretching); at
1597 cm1 (C¼C stretching); at 1632 cm1 (NH2 deformation
vibrations). The FTIR spectrum of SBE7-b-CD showed a broad peak
at between 3015 and 3760 cm1 (OH stretching vibration); a
peak at 2931 cm1 (CH stretching vibrations); peaks at
1159 cm1 and 1043 cm1 (CH and CO stretching vibrations).
Sulfisoxazole peaks were overlapped by CD peaks which makes the
identification of each compounds complicated at the spectra of
inclusion complex nanofibers. However, the sharpest absorption
peak of sulfisoxazole at about 1597 cm1 corresponding to CH
stretching vibration causes increase in intensity at that wavelength
of inclusion complex nanofiber. This result suggested that
sulfisoxazole is present in inclusion complex nanofibers.
Z.I. Yildiz et al. / International Journal of Pharmaceutics 531 (2017) 550–558 5573.4. Water-solubility of Sulfisoxazole/SBE7-b-CD-IC NF
As mentioned Section 2.3, excess amount of sulfisoxazole
(1.3 mg mL1) and sulfisoxazole/SBE7-b-CD-IC NF and sulfisox-
azole/SBE7-b-CD-IC powder having the same amount of sulfisox-
azole were added to water. In order to make comparison, the
solution of sulfisoxazole with concentration of its water solubility
(about 0.2 mg mL1) was also prepared to see water-solubility
enhancement. The plot (Fig. 9) shows that the solutions of
sulfisoxazole with 0.2 mg mL1 concentration and of sulfisoxazole
with 1.3 mg mL1 demonstrated peak at almost the same absor-
bance. On the other hand, sulfisoxazole/SBE7-b-CD-IC NF sample
solution having 1.3 mg mL1 of sulfisoxazole concentration
showed peak at 10 times higher absorbance. This shows that
the solubility of sulfisoxazole was increased by 10 times with
sulfisoxazole/SBE7-b-CD-IC NF formation. As seen from Fig. 9,
sulfisoxazole/SBE7-b-CD-IC powder also enhances water solubility
of sulfisoxazole due to formation of CD-IC, however sulfisoxazole/
SBE7-b-CD-IC NF shows higher absorbance than sulfisoxazole/
SBE7-b-CD-IC powder. The high surface area to volume ratio, high
porosity of nanofibers structure contribute to the enhancement of
water solubility of the drug (Sebe et al., 2015); therefore, the water
solubility enhancement in sulfisoxazole/SBE7-b-CD-IC NF become
higher compared to sulfisoxazole/SBE7-b-CD-IC powder. The fast-
dissolving property and water-solubility enhancement of the
sulfisoxazole in sulfisoxazole/SBE7-b-CD-IC NF and sulfisoxazole/
SBE7-b-CD-IC powder were also visually proven (Video S1, Video
S2 and Fig. 10). After addition of 5 mL water to the petri dishes,
while sulfisoxazole/SBE7-b-CD-IC NF was dissolved immediately,
the dissolution of sulfisoxazole/SBE7-b-CD-IC powder took place a
little bit slower than sulfisoxazole/SBE7-b-CD-IC NF sample and
the pure sulfisoxazole remain undissolved. This clearly showed the
fast-dissolving property of sulfisoxazole/SBE7-b-CD-IC NF along
with highly-increased water-solubility of sulfisoxazole by sulfi-
soxazole/SBE7-b-CD-IC NF formation.
4. Conclusions
In this study, free-standing and easily handled nanofibrous web
of sulfisoxazole/SBE7-b-CD-IC was successfully produced by using
electrospinning technique. The electrospun sulfisoxazole/SBE7-
b-CD-IC nanofibrous web has shown the fast-dissolving property
as well as the providing enhanced water-solubility to sulfisoxazole.
Based on our results, it is concluded that SBE7-b-CD is a good
candidate to form ICs with sulfisoxazole to increase its water-
solubility to a great extent. Moreover, electrospinning of nano-
fibers from sulfisoxazole/SBE7-b-CD-IC system having high surface
area to volume ratio and nano-scale porosity provides fast-
dissolving property. In brief, electrospinning of nanofibers/nano-
webs from drug/CD-ICs systems may provide novel approaches for
enhanced water-solubility and fast-dissolving tablet formulations
for drug delivery systems.
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